We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

633 hedge funds and large institutions have $12.4B invested in Charles River Laboratories in 2023 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 204 increasing their positions, 258 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 3 → 8 (+5)

34% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 70

22% more capital invested

Capital invested by funds: $10.1B → $12.4B (+$2.25B)

2% more funds holding

Funds holding: 621 → 633 (+12)

1.21% more ownership

Funds ownership: 101.05% → 102.25% (+1.2%)

21% less repeat investments, than reductions

Existing positions increased: 204 | Existing positions reduced: 258

32% less call options, than puts

Call options by funds: $54.7M | Put options by funds: $80.5M

Holders
633
Holders Change
+12
Holders Change %
+1.93%
% of All Funds
9.23%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
94
Increased
204
Reduced
258
Closed
70
Calls
$54.7M
Puts
$80.5M
Net Calls
-$25.8M
Net Calls Change
-$3.78M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$82.4M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$80.4M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$60.5M
4
MG
Meritage Group
California
+$53.4M
5
SCA
Southpoint Capital Advisors
New York
+$39.3M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$103M
2
ClearBridge Investments
ClearBridge Investments
New York
-$54.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$46.7M
4
CI Investments Inc
CI Investments Inc
Ontario, Canada
-$35.5M
5
FCM
Farallon Capital Management
California
-$28.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
201
EagleClaw Capital Management
Massachusetts
$3.81M -$918K -4,670 -22%
Royal London Asset Management
202
Royal London Asset Management
United Kingdom
$3.76M -$60K -305 -2%
Ensign Peak Advisors
203
Ensign Peak Advisors
Utah
$3.75M -$836K -4,249 -21%
AMI
204
Amica Mutual Insurance
Rhode Island
$3.75M – – –
AB
205
Amalgamated Bank
New York
$3.75M -$282K -1,433 -8%
RCM
206
Regency Capital Management
Hawaii
$3.7M +$3.08M +15,665 New
Mariner
207
Mariner
Kansas
$3.7M +$1.19M +6,071 +63%
SOADOR
208
State of Alaska Department of Revenue
Alaska
$3.65M -$109K -555 -3%
Jane Street
209
Jane Street
New York
$3.53M -$268K -1,363 -8%
Mirae Asset Global Investments
210
Mirae Asset Global Investments
South Korea
$3.5M -$125K -638 -4%
Brown Advisory
211
Brown Advisory
Maryland
$3.48M -$35.2K -179 -1%
AI
212
Atria Investments
North Carolina
$3.46M +$332K +1,688 +13%
AO
213
Advisor OS
Illinois
$3.39M -$35.2K -179 -1%
SFA
214
Sequoia Financial Advisors
Ohio
$3.34M +$2.57M +13,068 +1,257%
DekaBank Deutsche Girozentrale
215
DekaBank Deutsche Girozentrale
Germany
$3.33M +$1.38M +6,997 +99%
ASRS
216
Arizona State Retirement System
Arizona
$3.33M +$25K +127 +0.9%
SOMRS
217
State of Michigan Retirement System
Michigan
$3.32M – – –
RA
218
Royce & Associates
New York
$3.3M +$2.75M +13,975 New
FHB
219
First Hawaiian Bank
Hawaii
$3.27M -$25K -127 -0.9%
Nomura Asset Management
220
Nomura Asset Management
Japan
$3.23M +$248K +1,261 +10%
State of Tennessee, Department of Treasury
221
State of Tennessee, Department of Treasury
Tennessee
$3.2M -$333K -1,694 -11%
AIG
222
American International Group
New York
$3.18M -$22.6K -115 -0.8%
WR
223
WD Rutherford
Oregon
$3.18M -$134K -680 -4%
EAM
224
EFG Asset Management
Oregon
$3.17M -$118K -598 -4%
Corient Private Wealth
225
Corient Private Wealth
Florida
$3.16M +$1.4M +7,127 +114%
7 8
9
10 11

CRL Hedge Fund Activity: Q4 2023 in Review

633 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2023, worth a combined $12.4B — up 22% from $10.1B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new CRL positions and 70 closed out — a net gain of 24 holders — while 204 added to existing stakes and 258 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $82.4M. The largest seller was Fidelity Investments, cutting an estimated $103M.

  • 633 institutional investors held Charles River Laboratories (CRL) as of Q4 2023, up from 621 in Q3 2023.
  • Funds reported $12.4B of Charles River Laboratories stock for Q4 2023, up 22% quarter-over-quarter.
  • 94 funds opened new Charles River Laboratories positions in Q4 2023 and 70 closed out, a net change of +24 holders.
  • The largest Charles River Laboratories buyer in Q4 2023 was Morgan Stanley, an estimated $82.4M added.
  • The largest Charles River Laboratories seller in Q4 2023 was Fidelity Investments, an estimated $103M sold.

Based on aggregated 13F filings for Q4 2023.